BETA

BETA DRUGS

Small Cap BSE: 531481 NSE: BETA
₹779.00
-9 (-1.14%)
As on 30 September, 2022 | 03:25

Beta Drugs Share Price

Beta Drugs Performance

Day Range

  • Low
  • High

52 Week Range

  • Low
  • High
  • Open Price
  • Previous Close
  • Volume

Start SIP in BETA DRUGS

Start SIP

Beta Drugs Share Returns

  • Over 1 Month -2.5%
  • Over 3 Month 10.69%
  • Over 6 Month 36.67%
  • Over 1 Year 65.74%

Beta Drugs Key Statistics

P/E Ratio
PEG Ratio
Market Cap Cr 749
Price to Book Ratio 8.1
EPS 14.8
Dividend 0
Relative Strength Index 47.07
Money Flow Index 36.43
MACD Signal -0.7
Average True Range 29.91

Beta Drugs Investment Rating

  • Master Rating:
  • Beta Drugs has an operating revenue of Rs. 456.69 Cr. on a trailing 12-month basis. An annual revenue growth of 58% is outstanding, Pre-tax margin of 19% is great, ROE of 26% is exceptional. The company has a reasonable debt to equity of 13%, which signals a healthy balance sheet. The stock from a technical standpoint is trading close to its 50DMA and comfortably placed above its 200DMA, around 13% above 200DMA. It needs to take support around the 50 DMA level to continue further upside move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 75 which is a FAIR score but needs to improve its earnings, a RS Rating of 75 which is FAIR indicating the recent price performance, Buyer Demand at D+ which indicates heavy supply, Group Rank of 125 indicates it belongs to a poor industry group of Medical-Diversified and a Master Score of B is close to being the best. Institutional holding has remained stable in the last reported quarter. Overall, the stock definitely has some strength, you may want to examine it in more detail.

EPS Strength

Price Strength

Buyer Demand

Group Rank

Beta Drugs Financials
Indicator
Oper Rev Qtr Cr
Operating Expenses Qtr Cr
Operating Profit Qtr Cr
Depreciation Qtr Cr
Interest Qtr Cr
Tax Qtr Cr
Net Profit Qtr Cr

Beta Drugs Technicals

EMA & SMA

Current Price
779.
-9 (-1.14%)
  • Bullish Moving Average
  • ___
  • 0
  • Bearish Moving Average
  • ___
  • 0
  • 20 Day
  • 787.42
  • 50 Day
  • 782.97
  • 100 Day
  • 759.69
  • 200 Day
  • 697.39
  • 20 Day
  • 789
  • 50 Day
  • 795.63
  • 100 Day
  • 785.61
  • 200 Day
  • 697.34

Beta Drugs Resistance and Support

PIVOT
₹779.95
Resistance
First Resistance 807
Second Resistance 826
Third Resistance 853.05
RSI 47.07
MFI 36.43
MACD Single Line -0.7
MACD -3.22
Support
First Resistance 760.95
Second Resistance 733.9
Third Resistance 714.9

Beta Drugs Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 2,600 179,998 69.23
Week 5,160 431,995 83.72
1 Month 4,219 353,345 83.75
6 Month 7,048 536,535 76.13

Beta Drugs Result Highlights

Beta Drugs Synopsis

NSE-Medical-Diversified

Beta Drugs is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 124.85 Cr. and Equity Capital is Rs. 9.61 Cr. for the Year ended 31/03/2022. Beta Drugs Ltd. is a Public Limited Listed company incorporated on 21/09/2015 and has its registered office in the State of Himachal Pradesh, India. Company’s Corporate Identification Number(CIN) is L24230HP2005PLC028969 and registration number is 028969.
Market Cap 749
Sales 125
Shares in Float 0.32
No of funds 1
Yield
Book Value 9.67
U/D Vol ratio 0.7
LTDebt / Equity 7
Alpha 0.3
Beta 0.93

Beta Drugs

Owner NameJun-22Mar-22Dec-21Sep-21
Promoters 66.71%66.71%66.71%
Foreign Portfolio Investors 0.29%0.29%0.29%
Others 33%33%33%

Beta Drugs Management

Name Designation
Mr. Rahul Batra Chairman & Managing Director
Mr. Varun Batra Joint Managing Director
Mr. Balwant Singh Whole Time Director
Mrs. Seema Chopra Whole Time Director
Mr. Manmohan Khanna Independent Director
Mr. Rohit Parti Independent Director

Beta Drugs Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Beta Drugs Corporate Action

Date Purpose Remarks
2022-04-27 Audited Results
2021-10-25 Quarterly Results
2021-04-27 Audited Results
2020-10-19 Quarterly Results
2020-06-17 Others To consider Fund Raising

Beta Drugs FAQs

What is Share Price of Beta Drugs ?

Beta Drugs share price is ₹779 As on 30 September, 2022 | 03:11

What is the Market Cap of Beta Drugs ?

The Market Cap of Beta Drugs is ₹748.9 Cr As on 30 September, 2022 | 03:11

What is the P/E ratio of Beta Drugs ?

The P/E ratio of Beta Drugs is As on 30 September, 2022 | 03:11

What is the PB ratio of Beta Drugs ?

The PB ratio of Beta Drugs is 8.1 As on 30 September, 2022 | 03:11

Q1FY23